NewEdge Advisors’s Zimmer Biomet ZBH Stock Holding History

NewEdge Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$411K	Buy	4,779 +1,226	+35%	+$108K	﹤0.01%	2274
2026 Q1	$321K	Buy	3,553 +571	+19%	+$52.4K	﹤0.01%	2293
2025 Q4	$268K	Buy	2,982 +203	+7%	+$19.2K	﹤0.01%	2382
2025 Q3	$274K	Buy	2,779 +2,018	+265%	+$200K	﹤0.01%	2233
2025 Q2	$69.4K	Sell	761 -1,640	-68%	-$159K	﹤0.01%	2564
2025 Q1	$272K	Sell	2,401 -2,312	-49%	-$247K	﹤0.01%	1958
2024 Q4	$498K	Buy	4,713 +1,983	+73%	+$213K	﹤0.01%	1556
2024 Q3	$295K	Sell	2,730 -239	-8%	-$26.1K	﹤0.01%	1810
2024 Q2	$322K	Sell	2,969 -989	-25%	-$117K	﹤0.01%	1678
2024 Q1	$522K	Sell	3,958 -404	-9%	-$50.5K	﹤0.01%	1323
2023 Q4	$531K	Sell	4,362 -3,069	-41%	-$342K	0.01%	1256
2023 Q3	$834K	Sell	7,431 -1,605	-18%	-$204K	0.01%	947
2023 Q2	$1.32M	Sell	9,036 -599	-6%	-$81.4K	0.01%	745
2023 Q1	$1.31M	Sell	9,635 -110	-1%	-$13.8K	0.02%	685
2022 Q4	$1.21M	Buy	9,745 +3,191	+49%	+$370K	0.03%	457
2022 Q3	$685K	Buy	6,554 +3,674	+128%	+$403K	0.01%	814
2022 Q2	$303K	Buy	+2,880	New	+$342K	0.01%	1210
2022 Q1	–	Sell	-3,197	Closed	-$394K	–	1680
2021 Q4	$394K	Buy	+3,197	New	+$418K	0.01%	1193

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

NewEdge Advisors's ZBH Position: Q2 2026 in Review

NewEdge Advisors increased its Zimmer Biomet (ZBH) stake by 35% in Q2 2026, buying an estimated $108K and bringing the position to 4,779 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #2274.

NewEdge Advisors first reported a position in ZBH in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.32M in Q2 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

NewEdge Advisors held 4,779 shares of Zimmer Biomet worth $411K as of Q2 2026.
NewEdge Advisors bought 1,226 Zimmer Biomet shares in Q2 2026, an estimated $108K.
Zimmer Biomet made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2274 holding.
NewEdge Advisors first reported a position in Zimmer Biomet in Q4 2021 and has held it in 18 quarters since.
NewEdge Advisors's Zimmer Biomet position peaked at $1.32M in Q2 2023.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.